These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17547720)

  • 41. Nephrogenic systemic fibrosis and gadolinium-based contrast: medico-legal implications.
    Houck CM; Pristave RJ; Kannensohn KJ
    Semin Dial; 2008; 21(2):166-70. PubMed ID: 18226003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact on hospital policy: Yale experience.
    Weinreb JC
    J Am Coll Radiol; 2008 Jan; 5(1):53-6. PubMed ID: 18180010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case 35-2004: nephrogenic fibrosing dermopathy.
    Cowper SE; Bucala R; LeBoit PE
    N Engl J Med; 2005 Apr; 352(16):1723-4; author reply 1723-4. PubMed ID: 15846862
    [No Abstract]   [Full Text] [Related]  

  • 45. Images in clinical medicine. Nephrogenic fibrosing dermopathy.
    Garovic VD; Helgen KE
    N Engl J Med; 2007 Jul; 357(2):e2. PubMed ID: 17625120
    [No Abstract]   [Full Text] [Related]  

  • 46. Circulating fibrocytes: cellular basis for NSF.
    Bucala R
    J Am Coll Radiol; 2008 Jan; 5(1):36-9. PubMed ID: 18180007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrogenic systemic fibrosis: a clinicopathologic study of 6 cases.
    Pryor JG; Scott GA
    J Am Acad Dermatol; 2007 Nov; 57(5):902-3. PubMed ID: 17939944
    [No Abstract]   [Full Text] [Related]  

  • 48. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS; Marckmann P
    Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.
    High WA
    Arch Dermatol; 2009 Oct; 145(10):1178-82. PubMed ID: 19841408
    [No Abstract]   [Full Text] [Related]  

  • 50. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
    J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
    Thomsen HS; Marckmann P
    Eur J Radiol; 2008 May; 66(2):153-9. PubMed ID: 18343071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE; Rabach M; Girardi M
    Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR; Jagirdar J
    J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into nephrogenic systemic fibrosis.
    Swaminathan S; Shah SV
    J Am Soc Nephrol; 2007 Oct; 18(10):2636-43. PubMed ID: 17855637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrogenic systemic fibrosis--the need for a multidisciplinary approach.
    Nortier JL; del Marmol V
    Nephrol Dial Transplant; 2007 Nov; 22(11):3097-101. PubMed ID: 17617650
    [No Abstract]   [Full Text] [Related]  

  • 58. Nephrogenic systemic fibrosis: epidemiology update.
    Marckmann P
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):315-9. PubMed ID: 18408485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum.
    Naylor E; Hu S; Robinson-Bostom L
    J Am Acad Dermatol; 2008 Jan; 58(1):149-50. PubMed ID: 18158925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P; Skov L
    Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.